These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12454693)

  • 1. Pathophysiology of Peyronie's disease.
    Moreland RB; Nehra A
    Int J Impot Res; 2002 Oct; 14(5):406-10. PubMed ID: 12454693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease.
    Piao S; Ryu JK; Shin HY; Zhang L; Song SU; Han JY; Park SH; Kim JM; Kim IH; Kim SJ; Suh JK
    Int J Androl; 2008 Jun; 31(3):346-53. PubMed ID: 17651407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biomechanical model of Peyronie's disease.
    Gefen A; Chen J; Elad D
    J Biomech; 2000 Dec; 33(12):1739-44. PubMed ID: 11006403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentations of Peyronie's disease.
    Pryor JP; Ralph DJ
    Int J Impot Res; 2002 Oct; 14(5):414-7. PubMed ID: 12454695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal: trauma as the cause of the Peyronie's lesion.
    Devine CJ; Somers KD; Jordan SG; Schlossberg SM
    J Urol; 1997 Jan; 157(1):285-90. PubMed ID: 8976281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction.
    Iacono F; Barra S; De Rosa G; Boscaino A; Lotti T
    J Urol; 1993 Dec; 150(6):1806-9. PubMed ID: 8230510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transverse septum-like plaque of Peyronie's disease in a young man.
    Yanagisawa Y; Nakamoto T; Ogawa A
    Int Urol Nephrol; 1986; 18(1):85-8. PubMed ID: 3721768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peyronie's Disease.
    Taylor FL; Levine LA
    Urol Clin North Am; 2007 Nov; 34(4):517-34, vi. PubMed ID: 17983892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.
    Li J; Wang S; Qin F; Zhu M; You X; Wu C; Fu F; Yuan J
    Andrologia; 2018 Sep; 50(7):e13051. PubMed ID: 29806152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated Micro-Trauma of the Penile Tunica Albuginea: A New Animal Model of Peyronie's Disease.
    Jiang H; Gao Q; Che X; Zhu L; Zhang Z; Chen Y; Dai Y
    Urol Int; 2018; 100(2):228-239. PubMed ID: 29151107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the paradigm for plaque development in Peyronie's disease.
    Mulhall JP
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S93-102. PubMed ID: 14551585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.
    Zorba OU; Sirma S; Ozgon G; Salabas E; Ozbek U; Kadioglu A
    Adv Clin Exp Med; 2012; 21(5):607-14. PubMed ID: 23356197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New discoveries in the basic science understanding of Peyronie's disease.
    Jalkut M; Gonzalez-Cadavid N; Rajfer J
    Curr Urol Rep; 2004 Dec; 5(6):478-84. PubMed ID: 15541219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie's disease.
    Hassoba H; El-Sakka A; Lue T
    Egypt J Immunol; 2005; 12(1):1-8. PubMed ID: 16734133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peyronie's disease: advances in basic science and pathophysiology.
    Bivalacqua TJ; Purohit SK; Hellstrom WJ
    Curr Urol Rep; 2000 Dec; 1(4):297-301. PubMed ID: 12084307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
    Paulis G; Brancato T
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomechanical aspects of Peyronie's disease in development stages and following reconstructive surgeries.
    Gefen A; Elad D; Chen J
    Int J Impot Res; 2002 Oct; 14(5):389-96. PubMed ID: 12454691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peyronie's disease: a review.
    Gholami SS; Gonzalez-Cadavid NF; Lin CS; Rajfer J; Lue TF
    J Urol; 2003 Apr; 169(4):1234-41. PubMed ID: 12629334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbation of cell cycle regulators in Peyronie's disease.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    Int J Impot Res; 2001 Dec; 13 Suppl 5():S21-8. PubMed ID: 11781743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.